BiovaxID(R) Personalized Lymphoma Vaccine is Featured in Article Published in ... MarketWatch (press release) According to the article, "This vaccine (BiovaxID) opens new doors because, as great a drug as rituximab is, even in combination with chemotherapy, it does not cure patients with follicular lymphoma," Dr. Kwak said. "The ultimate goal of curing ... |
